Manage Account
Change Password
Sign Out
UserName
Profession Email
Profession Email
Children with uncontrolled moderate-to-severe asthma may benefit from treatment with dupilumab which reduced exacerbations and improved lung function, according to results of the phase III VOYAGE study presented at ATS 2021.
